Biochemistry Research InternationalVolume 2012 (2012), Article ID 247275, 5 pagesdoi:10.1155/2012/247275

Review Article

Endoplasmic Reticulum Stress-Associated Lipid Droplet Formation and Type II Diabetes

Xuebao Zhang¹ and Kezhong Zhang1,2,3

¹Center for Molecular Medicine and Genetics, The Wayne State University School of Medicine, 540 East Canfield Avenue, Detroit, MI 48201, USA²Department of Immunology and Microbiology, The Wayne State University School of Medicine, Detroit, MI 48201, USA³Karmanos Cancer Institute, The Wayne State University School of Medicine, Detroit, MI 48201, USA

Received 2 September 2011; Revised 14 November 2011; Accepted 15 November 2011

Academic Editor: Huiping Zhou

Copyright © 2012 Xuebao Zhang and Kezhong Zhang. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Diabetes mellitus (DM), a metabolic disorder characterized by hyperglycemia, is caused by insufficient insulin production due to excessive loss of pancreatic β cells (type I diabetes) or impaired insulin signaling due to peripheral insulin resistance (type II diabetes). Pancreatic β cell is the only insulin-secreting cell type that has highly developed endoplasmic reticulum (ER) to cope with high demands of insulin synthesis and secretion. Therefore, ER homeostasis is crucial to the proper function of insulin signaling. Accumulating evidence suggests that deleterious ER stress and excessive intracellular lipids in nonadipose tissues, such as myocyte, cardiomyocyte, and hepatocyte, cause pancreatic β-cell dysfunction and peripheral insulin resistance, leading to type II diabetes. The excessive deposition of lipid droplets (LDs) in specialized cell types, such as adipocytes, hepatocytes, and macrophages, has been found as a hallmark in ER stress-associated metabolic diseases, including obesity, diabetes, fatty liver disease, and atherosclerosis. However, much work remains to be done in understanding the mechanism by which ER stress response regulates LD formation and the pathophysiologic role of ER stress-associated LD in metabolic disease. This paper briefly summarizes the recent advances in ER stress-associated LD formation and its involvement in type II diabetes.

1. Introduction to ER Stress

ER is an intracellular organelle where dynamic protein folding and assembly, storing cellular calcium, and lipid biosynthesis occur. A variety of biochemical or pathophysiological stimuli can interrupt protein folding process in the ER by disrupting protein glycosylation, disulfide bond formation, or ER calcium pool. These disruptions can cause the accumulation of unfolded or misfolded proteins in the ER lumen, a condition termed as “ER stress” [1, 2]. To protect cells from proteotoxicity caused by ER stress, the unfolded protein response (UPR) is activated through attenuating general protein translation, increasing in protein folding capacity, and expediting degradation of misfolded proteins. Three major ER stress sensors or transducers have been found: inositol-requiring 1α (IRE1α), double-stranded RNA-dependent protein kinase- (PKR-) like ER kinase (PERK), and activating transcription factor 6 (ATF6), which have been comprehensively reviewed [2, 3]. The UPR signaling, mediated through ER stress sensors, modulates transcriptional and translation programs in cells under ER stress. As a double-edged sword, the UPR provides survival signals at the initial phase of stress response, leading to cell adaption to ER stress [1, 2, 4]. When ER stress gets prolonged, the UPR can induce cell death programs to kill the stressed cells. In recent years, the scope and consequence of ER stress and UPR have been significantly expanded. Many pathophysiologic stimuli, such as oxidative stress, proinflammatory stimuli, fatty acids, and energy fluctuations, can directly or indirectly cause ER stress and the UPR activation in specialized cell types, such as macrophages, hepatocytes, and pancreatic β cells [2, 5]. The UPR signaling is fundamental to the initiation and progress of a variety of diseases, including metabolic disease, cancer, cardiovascular disease, and neurodegenerative disease [2, 6, 7].

2. LD Formation

LD, also known as adiposome or fat body, has been found ubiquitously present in lipid-overloaded cells from yeast to mammals [8, 9]. For a long time, LD was thought simply as an inert lipid storage reservoir since its earliest description in 19th century. The discovery of perilipin, an LD-associated protein that coats LD in adipocytes, makes researchers to challenge the understanding of LD as lipid storage [10]. LD is now recognized as a dynamic organelle composed of a monolayer phospholipid, embedded with numerous proteins without transmembrane spanning domains, and a hydrophobic core that contains triacylglycerols (TGs) and sterol esters [11, 12]. TGs are the key neutral lipid required for LDs formation in adipocytes. Deletion of genes encoding enzymes responsible for neutral lipid synthesis eliminated LDs formation [13]. Evidence showed that, without DGAT enzymes, LDs cannot form in adipocytes. Therefore, by segregation of extra TG or hydrophobic molecules into LDs, cells are protected from lipotoxicity. These features make LD a regulatory organelle in lipid homeostasis. The biogenesis and assembly of LD are still largely unknown. It has been suggested that ER is the site where LD is synthesized and assembled. Over ninety percent of LDs were found in close apposition to the ER [14]. ER budding model, Bicelle model, and vesicular budding model have been suggested to explain how LD is formed in ER [15]. Perhaps, the most accepted model is ER budding model in which LD originated between the two leaflets of ER bilayer buds into the cytosol. Newly formed LD can increase its size (0.2 μm–20 μm in diameter) by homotypic fusion that depends on microtubule system, most likely motor protein dynein. Under this mechanism, the growth of LD may proceed without ongoing biosynthesis of TGs and sterol esters [16, 17].

3. ER Stress and LD Formation

LD formation has been proposed as an exit model in the removal of unfolded or misfolded proteins or some ubiquitinated proteins from the ER [18, 19]. LD may serve as a transient depot to sequester unfolded or misfolded as well as excessive proteins to alleviate ER stress (Figure 1). Diverse groups of LD-associated proteins were found in yeast S. cerevisiae, Drosophila embryos, and human hepatocyte cell line Huh7 [20–22]. Some of the LD-associated proteins, such as Acl-CoA synthetases, lanosterol synthetase, and GAPDH, are conserved from yeast to human. The proteins detected in LD seem to be specific, since the organelle-specific proteins, including lactate dehydrogenase (LDH) (cytosolic marker), integrin (plasma membrane marker), calnexin (ER marker), and GS28 (Golgi marker), were hardly detected in LD fractions [22]. Interestingly, a number of proteins which were thought to be organelle-specific, including histones (nucleus), caveolins (plasma membrane), HSP70 (cytosol), ApoB (ER), and Nir2 (Golgi), were detected in LD fraction [23]. Furthermore, LD dynamically interacts with ER, peroxisomes, mitochondria, and plasma membrane [15]. LD can be transported along microtubules, following the same way that the ER, Golgi, and mitochondria were positioned and delivered [24]. It was proposed that the dynamical interactions between LD and the other compartments facilitate the exchange of proteins and lipids in cells. The LD is functionally and structurally similar to the extracellular counterpart of lipoprotein particles [15, 21]. This notion was supported by the finding that LD provides a platform for degradation of excessive ApoB protein by converging ubiquitin-proteasomal and autophagy-lysosomal pathways, thereby preventing cytotoxicity resulted from aggregation of excessive proteins [25]. Previous studies have shown that disruption of ER functions leads to the accumulation of intracellular lipids [26–28]. Disrupted protein glycosylation or ER-associated protein degradation by ER stress-inducing reagents, such as tunicamycin and brefeldin, has been demonstrated to increase LD accumulation in budding yeast Saccharomyces cerevisiae or mammalian cells [28, 29]. Previously, it is known that intracellular LD formation is through the lipogenic program activated by sterol regulatory element-binding proteins (SREBPs). Recent study suggested that more ER-localized, stress-responsive protein factors, such as hepatocyte-specific cAMP responsive element-binding protein (CREBH), can also regulate lipogenic programs to promote LD formation under metabolic stress signals, such as insulin and saturated fatty acids [30]. Moreover, ER stress response may directly facilitate LD synthesis and assembly as a mechanism to defend intracellular stress [29, 31] (Figure 1). This is consistent with the observations that lipids can be recruited to the stressed cells to sequester misfolded proteins in the ER at the early stage of ER stress and that the ER is expanded significantly to alleviated ER stress independent of the UPR [23, 32].

Figure 1: Interactions between ER stress, oxidative stress, and lipid droplets in type II diabetes. LD, lipid droplet; UPR, unfolded protein response.

4. LD Formation and Type II Diabetes

Previous studies demonstrated that excessive accumulation of lipids in peripheral tissues is closely associated with insulin resistance in type II diabetes [33, 34]. Although ER stress and UPR pathways in metabolic disease have been extensively reviewed, ER stress-associated LD formation, which is independent of UPR pathway, did not draw much attention. The interaction between LD and mitochondrial might affect the peripheral tissue insulin resistance [35, 36] (Figure 1). Recent studies indicated that insulin resistance is not simply associated with the amount of intracellular lipids. Despite elevated lipids content in skeletal muscle of the trained enduring athletes, the insulin-signal in these individuals is still markedly sensitive [36]. The combination of weight loss and physical activity in obesity improves insulin sensitivity and reduces the size of LD, but not the overall intramyocellular lipid [37]. One possible explanation for these phenomena is that increased mitochondrial oxidative activity for lipid oxidation may decrease insulin resistance. This is supported by the facts that lower oxidative capacity is found in insulin resistant skeletal muscle and that exercise can improve the capacity for lipid oxidation [36]. Several mitochondrial proteins including prohibitin, a subunit of ATP synthase, and pyruvate carboxylase were identified in LD fractions by proteomic analysis [35]. In addition, numerous lipid metabolic enzymes, such as hormone-sensitive lipase, lanosterol synthase, and acyl-CoA synthetase, were also found to be associated with LD complex, and the overall LD protein composition can be changed in response to lipolysis stimulation [35, 38]. Despite these observations, further study is required to explore how mitochondria communicate and interact with LD in metabolic processes.

Fat-specific protein 27 (Fsp27) is a member of cell death-inducing DNA fragmentation factor family proteins that is localized to LD. Fsp27 plays an important role in lipid storage and mitochondrial activity in adipocytes [39–41]. Genetic depletion of Fsp27 in mice is characterized by increased glucose uptake, improved insulin sensitivity, and significantly increased mitochondrial metabolism [39, 40]. Small sizes of LDs and increased mitochondrial activity were found in Fsp27-deficient white adipocytes, suggesting that ectopic LD formation represents an imbalance between lipid supply and lipid oxidation in peripheral tissue. Likely, LD-associated proteins and the interactions between LD and the other intracellular organelles may play direct roles in the pathogenesis of diabetes [42]. Type II diabetes is often correlated with increased serum levels of proinflammatory cytokines secreted by ER stress-activated macrophage. Previous research demonstrated that the proinflammatory cytokine TNFα blunts the insulin signaling pathway therefore causing insulin resistance by activating the JNK1/2 signaling pathway which is involved in serine phosphorylation of IRS1 (insulin receptor substrate 1) [43, 44]. However, a new study by Ranjit found that proinflammatory cytokines, such as TNFα, IL1β, and INFγ, act on lipolysis by decreasing the expression of FSP27 and the size of LD in adipocytes [45]. Since decreased FSP27 is evidenced to improve insulin resistance and LDs, it is likely that the proinflammatory cytokines play double-edged roles in type II diabetes.

5. Conclusion

Accumulating evidence demonstrated a strong link between ER stress, LD formation, and type II diabetes. It is important to note that ER stress response is a fundamental stress signaling underlying many life styles, such as air pollution, chronic alcohol consumption, and smoking, which may be associated with the development of metabolic disease [46–48]. Therefore, for the future research, it is important to delineate ER mechanisms in LD formation that is associated with the development of type II diabetes. Key questions include what is the mechanism by which ER stress regulates LD formation? Is there any ER chaperones or UPR targets present in the LD complex? Does ER stress-associated LD formation provide survival or devastating pathways in the progression of type II diabetes? Is it possible to modulate LD formation by targeting ER stress signaling? Answering these questions will benefit and direct the future understanding and treatment of type II diabetes and the other types of metabolic disease.

Acknowledgments

Portion of the research work in the Zhang laboratory is supported by American Heart Association Grants 09GRNT2280479; National Institutes of Health Grants DK090313 and ES017829 (K. Zhang)

References

K. Zhang and R. J. Kaufman, “Signaling the unfolded protein response from the endoplasmic reticulum,” Journal of Biological Chemistry, vol. 279, no. 25, pp. 25935–25938, 2004.

D. Ron and P. Walter, “Signal integration in the endoplasmic reticulum unfolded protein response,” Nature Reviews Molecular Cell Biology, vol. 8, no. 7, pp. 519–529, 2007.

M. Schroder and R. J. Kaufman, “The mammalian unfolded protein response,” Annual Review of Biochemistry, vol. 74, pp. 739–789, 2005.

C. Rubio, D. Pincus, A. Korennykh, S. Schuck, H. El-Samad, and P. Walter, “Homeostatic adaptation to endoplasmic reticulum stress depends on Ire1 kinase activity,” Journal of Cell Biology, vol. 193, no. 1, pp. 171–184, 2011.

K. Zhang and R. J. Kaufman, “From endoplasmic-reticulum stress to the inflammatory response,” Nature, vol. 454, no. 7203, pp. 455–462, 2008.

H. Yoshida, “ER stress and diseases,” FEBS Journal, vol. 274, no. 3, pp. 630–658, 2007.

R. J. Kaufman, “Orchestrating the unfolded protein response in health and disease,” Journal of Clinical Investigation, vol. 110, no. 10, pp. 1389–1398, 2002.

M. K. Clausen, K. Christiansen, P. K. Jensen, and O. Behnke, “Isolation of lipid particles from baker's yeast,” FEBS Letters, vol. 43, no. 2, pp. 176–179, 1974.

K. Christiansen and P. K. Jensen, “Membrane-bound lipid particles from beef heart chemical composition and structure,” Biochimica et Biophysica Acta, vol. 260, no. 3, pp. 449–459, 1972.

A. S. Greenberg, J. J. Egan, S. A. Wek, N. B. Garty, E. J. Blanchette-Mackie, and C. Londos, “Perilipin, a major hormonally regulated adipocyte-specific phosphoprotein associated with the periphery of lipid storage droplets,” Journal of Biological Chemistry, vol. 266, no. 17, pp. 11341–11346, 1991.

D. A. Brown, “Lipid droplets: proteins floating on a pool of fat,” Current Biology, vol. 11, no. 11, pp. R446–R449, 2001.

P. T. Bozza and J. P. B. Viola, “Lipid droplets in inflammation and cancer,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 82, no. 4–6, pp. 243–250, 2010.

C. A. Harris, J. T. Haas, R. S. Streeper et al., “DGAT enzymes are required for triacylglycerol synthesis and lipid droplets in adipocytes,” Journal of Lipid Research, vol. 52, no. 4, pp. 657–667, 2011.

K. M. Szymanski, D. Binns, R. Bartz et al., “The lipodystrophy protein seipin is found at endoplasmic reticulum lipid droplet junctions and is important for droplet morphology,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 52, pp. 20890–20895, 2007.

Y. Guo, K. R. Cordes, R. V. Farese Jr., and T. C. Walther, “Lipid droplets at a glance,” Journal of Cell Science, vol. 122, no. 6, pp. 749–752, 2009.

P. Bostrom, L. Andersson, L. Li et al., “The assembly of lipid droplets and its relation to cellular insulin sensitivity,” Biochemical Society Transactions, vol. 37, no. 5, pp. 981–985, 2009.

P. Bostrom, M. Rutberg, J. Ericsson, et al., “Cytosolic lipid droplets increase in size by microtubule-dependent complex formation,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, pp. 1945–1951, 2005.

H. L. Ploegh, “A lipid-based model for the creation of an escape hatch from the endoplasmic reticulum,” Nature, vol. 448, no. 7152, pp. 435–438, 2007.

I. Z. Hartman, P. S. Liu, J. K. Zehmer et al., “Sterol-induced dislocation of 3-Hydroxy-3-methylglutaryl coenzyme a reductase from endoplasmic reticulum membranes into the cytosol through a subcellular compartment resembling lipid droplets,” Journal of Biological Chemistry, vol. 285, no. 25, pp. 19288–19298, 2010.

K. Athenstaedt, D. Zweytick, A. Jandrositz, S. D. Kohlwein, and G. Daum, “Identification and characterization of major lipid particle proteins of the yeast Saccharomyces cerevisiae,” Journal of Bacteriology, vol. 181, no. 20, pp. 6441–6448, 1999.

S. Cermelli, Y. Guo, S. P. Gross, and M. A. Welte, “The lipid-droplet proteome reveals that droplets are a protein-storage depot,” Current Biology, vol. 16, no. 18, pp. 1783–1795, 2006.

Y. Fujimoto, H. Itabe, J. Sakai et al., “Identification of major proteins in the lipid droplet-enriched fraction isolated from the human hepatocyte cell line HuH7,” Biochimica et Biophysica Acta, vol. 1644, no. 1, pp. 47–59, 2004.

M. A. Welte, “Proteins under new management: lipid droplets deliver,” Trends in Cell Biology, vol. 17, no. 8, pp. 363–369, 2007.

M. A. Welte, S. Cermelli, J. Griner et al., “Regulation of lipid-droplet transport by the perilipin homolog LSD2,” Current Biology, vol. 15, no. 14, pp. 1266–1275, 2005.

Y. Ohsaki, J. Cheng, A. Fujita, T. Tokumoto, and T. Fujimoto, “Cytoplasmic lipid droplets are sites of convergence of proteasomal and autophagic degradation of apolipoprotein B,” Molecular Biology of the Cell, vol. 17, no. 6, pp. 2674–2683, 2006.

A. J. Kim, Y. Shi, R. C. Austin, and G. H. Werstuck, “Valproate protects cells fom ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3,” Journal of Cell Science, vol. 118, no. 1, pp. 89–99, 2005.

G. H. Werstuck, S. R. Lentz, S. Dayal et al., “Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways,” Journal of Clinical Investigation, vol. 107, no. 10, pp. 1263–1273, 2001.

W. Fei, H. Wang, C. Bielby, and H. Yang, “Conditions of endoplasmic reticulum stress stimulate lipid droplet formation in Saccharomyces cerevisiae,” Biochemical Journal, vol. 424, no. 1, pp. 61–67, 2009.

J.-S. Lee, R. Mendez, H. H. Heng, Z. Yang, and K. Zhang, “Pharmacological ER stress promotes hepatic lipogenesis and lipid droplet formation,” American Journal of Translational Research, vol. 4, pp. 102–113, 2012.

C. Zhang, G. Wang, Z. Zheng, et al., “Endoplasmic reticulum-tethered transcription factor cAMP responsive element-binding protein, hepatocyte specific, regulates hepatic lipogenesis, fatty acid oxidation, and lipolysis upon metabolic stress in mice,” Hepatology. In press

K. Zhang, S. Wang, J. Malhotra, et al., “The unfolded protein response transducer IRE1alpha prevents ER stress-induced hepatic steatosis,” The EMBO Journal, vol. 30, pp. 1357–1375, 2011.

S. Schuck, W. A. Prinz, K. S. Thorn, C. Voss, and P. Walter, “Membrane expansion alleviates endoplasmic reticulum stress independently of the unfolded protein response,” Journal of Cell Biology, vol. 187, no. 4, pp. 525–536, 2009.

S. E. Thomas, L. E. Dalton, M. L. Daly, E. Malzer, and S. J. Marciniak, “Diabetes as a disease of endoplasmic reticulum stress,” Diabetes/Metabolism Research and Reviews, vol. 26, no. 8, pp. 611–621, 2010.

D. Scheuner and R. J. Kaufman, “The unfolded protein response: a pathway that links insulin demand with β-cell failure and diabetes,” Endocrine Reviews, vol. 29, no. 3, pp. 317–333, 2008.

D. L. Brasaemle, G. Dolios, L. Shapiro, and R. Wang, “Proteomic analysis of proteins associated with lipid droplets of basal and lipolytically stimulated 3T3-L1 adipocytes,” Journal of Biological Chemistry, vol. 279, no. 5, pp. 46835–46842, 2004.

B. H. Goodpaster, J. He, S. Watkins, and D. E. Kelley, “Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 12, pp. 5755–5761, 2001.

J. He, B. H. Goodpaster, and D. E. Kelley, “Effects of weight loss and physical activity on muscle lipid content and droplet size,” Obesity Research, vol. 12, no. 5, pp. 761–769, 2004.

J. G. Granneman, H. P. Moore, R. L. Granneman, A. S. Greenberg, M. S. Obin, and Z. Zhu, “Analysis of lipolytic protein trafficking and interactions in adipocytes,” Journal of Biological Chemistry, vol. 282, no. 8, pp. 5726–5735, 2007.

Z. Nian, Z. Sun, L. Yu, S. Y. Toh, J. Sang, and P. Li, “Fat-specific protein 27 undergoes ubiquitin-dependent degradation regulated by triacylglycerol synthesis and lipid droplet formation,” Journal of Biological Chemistry, vol. 285, no. 13, pp. 9604–9615, 2010.

S. Y. Toh, J. Gong, G. Du et al., “Up-regulation of mitochondrial activity and acquirement of brown adipose tissue-like property in the white adipose tissue of Fsp27 deficient mice,” PLoS One, vol. 3, no. 8, Article ID e2890, 2008.

N. Nishino, Y. Tamori, S. Tateya et al., “FSP27 contributes to efficient energy storage in murine white adipocytes by promoting the formation of unilocular lipid droplets,” Journal of Clinical Investigation, vol. 118, no. 8, pp. 2808–2821, 2008.

M. A. Abdul-Ghani and R. A. Defronzo, “Pathogenesis of insulin resistance in skeletal muscle,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 476279, 19 pages, 2010.

H. A. Tuttle, G. Davis-Gorman, S. Goldman, J. G. Copeland, and P. F. McDonagh, “Proinflammatory cytokines are increased in type 2 diabetic women with cardiovascular disease,” Journal of Diabetes and Its Complications, vol. 18, no. 6, pp. 343–351, 2004.

S. Fernandez-Veledo, R. Vila-Bedmar, I. Nieto-Vazquez, and M. Lorenzo, “C-Jun N-terminal kinase 1/2 activation by tumor necrosis factor-α induces insulin resistance in human visceral but not subcutaneous adipocytes: reversal by liver X receptor agonists,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 9, pp. 3583–3593, 2009.

S. Ranjit, E. Boutet, P. Gandhi et al., “Regulation of fat specific protein 27 by isoproterenol and TNF-α to control lipolysis in murine adipocytes,” Journal of Lipid Research, vol. 52, no. 2, pp. 221–236, 2011.

S. Laing, G. Wang, T. Briazova et al., “Airborne particulate matter selectively activates endoplasmic reticulum stress response in the lung and liver tissues,” American Journal of Physiology, vol. 299, no. 4, pp. C736–C749, 2010.

S. J. Pandol, F. S. Gorelick, A. Gerloff, and A. Lugea, “Alcohol abuse, endoplasmic reticulum stress and pancreatitis,” Digestive Diseases, vol. 28, no. 6, pp. 776–782, 2010.

E. Jorgensen, A. Stinson, L. Shan, J. Yang, D. Gietl, and A. P. Albino, “Cigarette smoke induces endoplasmic reticulum stress and the unfolded protein response in normal and malignant human lung cells,” BMC Cancer, vol. 8, article 229, 2008.